- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Barbara Ryan
Articles
More than Ever, Data Will Dictate Future Fortunes
Is stock market outperformance for biotech still in the cards for 2023?
Data Signals Some Green Shoots for Biotech in 2023
Chronicling the market’s rise and fall—and signs of potential recovery.
Biopharma Investment Implications: Looking Back and Forward
What a changing economy and related trends could mean for 2023.
Female Board Members Are Good for Business
Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.
Back in Person, Sparks Could Fly at Upcoming J.P. Morgan Conference
Will biopharma investment heat up and signal better fortunes for 2023?
The New Reality for Industry Dealmaking May be Setting In
Focus is on cash: who’s got it, who doesn’t, and what will it mean?